Free Trial

Brookstone Capital Management Invests $4.17 Million in Kenvue Inc. (NYSE:KVUE)

Kenvue logo with Consumer Staples background

Brookstone Capital Management acquired a new stake in shares of Kenvue Inc. (NYSE:KVUE - Free Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 173,679 shares of the company's stock, valued at approximately $4,165,000.

Several other large investors have also recently added to or reduced their stakes in KVUE. Cambridge Investment Research Advisors Inc. raised its position in shares of Kenvue by 4.0% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 106,140 shares of the company's stock valued at $2,545,000 after purchasing an additional 4,034 shares during the period. Steward Partners Investment Advisory LLC lifted its position in Kenvue by 143.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock worth $1,023,000 after acquiring an additional 28,216 shares during the last quarter. Starboard Value LP acquired a new position in Kenvue during the 4th quarter worth $467,864,000. TrueMark Investments LLC boosted its holdings in Kenvue by 9.3% during the fourth quarter. TrueMark Investments LLC now owns 190,595 shares of the company's stock valued at $4,069,000 after acquiring an additional 16,161 shares during the period. Finally, Kingswood Wealth Advisors LLC acquired a new stake in shares of Kenvue in the first quarter valued at about $413,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on KVUE shares. Redburn Atlantic began coverage on Kenvue in a research note on Thursday, April 10th. They set a "neutral" rating and a $23.50 target price for the company. UBS Group increased their price target on shares of Kenvue from $24.00 to $25.00 and gave the company a "neutral" rating in a report on Friday, May 9th. Citigroup reaffirmed a "neutral" rating on shares of Kenvue in a research report on Friday, June 13th. Barclays boosted their price target on shares of Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a report on Monday, May 12th. Finally, Evercore ISI began coverage on shares of Kenvue in a research note on Monday, March 24th. They issued an "in-line" rating and a $25.00 target price on the stock. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $25.33.

Check Out Our Latest Report on Kenvue

Kenvue Price Performance

NYSE:KVUE traded down $0.13 on Monday, reaching $20.92. The stock had a trading volume of 11,615,630 shares, compared to its average volume of 16,123,322. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market capitalization of $40.14 billion, a P/E ratio of 19.14, a price-to-earnings-growth ratio of 3.27 and a beta of 0.83. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $25.17. The stock has a fifty day moving average price of $22.61 and a 200-day moving average price of $22.32.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.01. The business had revenue of $3.74 billion for the quarter, compared to analyst estimates of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. Kenvue's revenue for the quarter was down 3.9% on a year-over-year basis. During the same period in the prior year, the company earned $0.28 EPS. Research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.92%. The ex-dividend date was Wednesday, May 14th. Kenvue's payout ratio is presently 149.09%.

About Kenvue

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Featured Stories

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Should You Invest $1,000 in Kenvue Right Now?

Before you consider Kenvue, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.

While Kenvue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Made in America Stocks Under $20 You Need to See!
3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines